Investors Willing to Wait on Novartis (NVS) Could Reap Dividends - Barron's Nov 21, 2012 08:37AM
Novartis (NVS) Could Formulate Strong Results in 2012 - Barron's Mar 19, 2012 04:47PM
Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's Mar 2, 2012 11:46AM
Teva (TEVA) May Be One of the Cheapest Pharmas Right Now - Barron's Aug 26, 2011 07:30AM
Momenta (MNTA) Blood Thinner Could Thicken Your Portfolio - Barron's Feb 16, 2011 10:09AM